GLUCOA1C KIT DE PRUEBA DE GLICOHEMOGLOBINA
Mexico·Clase II·III. DIAGNOSTIC AGENTS·KANA UNDESA, S.A. DE C.V.·Registered March 27, 2019PRUEBA MEDICIÓN CUANTITATIVA DEL NIVEL DE HEMOGLOBINA (HBA1C) EN MUESTRAS DE SANGRE TOTAL (SANGRE CAPILAR O VENOSA)
QUANTITATIVE HEMOGLOBIN LEVEL MEASUREMENT TEST (HBA1C) IN WHOLE BLOOD SAMPLES (CAPILLARY OR VENOUS BLOOD)
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA MEDICIÓN CUANTITATIVA DEL NIVEL DE HEMOGLOBINA (HBA1C) EN MUESTRAS DE SANGRE TOTAL (SANGRE CA
- Trade Name (English)
- QUANTITATIVE HEMOGLOBIN LEVEL MEASUREMENT TEST (HBA1C) IN WHOLE BLOOD SAMPLES (CA BLOOD
- Analysis ID
- 640R2019 SSA
- Registration Date
- March 27, 2019
- Name (Spanish)
- KANA UNDESA, S.A. DE C.V.
- Name (English)
- KANA UNDESA, S.A. DE C.V.
Access comprehensive regulatory information for GLUCOA1C KIT DE PRUEBA DE GLICOHEMOGLOBINA (GLUCOA1C GLYCOHEMOGLOBIN TEST KIT) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 640R2019 SSA and manufactured by KANA UNDESA, S.A. DE C.V.. The device was registered on March 27, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.